Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors

Clinical trial NCT04925609 · RECRUITING

Trial details

NCT number: NCT04925609
Sponsor: Princess Maxima Center for Pediatric Oncology
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anaplastic Large Cell Lymphoma, ALK-Positive Inflammatory Myofibroblastic Tumor Other Solid Tumor

Start date: 2022-08-18
Primary completion: 2033-12-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.